Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer

Annals of Surgical Oncology

Volumn 10, Issue 4, 2003, Pages 348-354

  Scaife, Courtney L ^a   Curley, Steven A ^a   Izzo, Francesco ^b   Marra, Paolo ^b   Delrio, Paolo ^b   Daniele, Bruno ^b   Cremona, Franco ^b   Gershenwald, Jeffrey E ^a   Chase, Judy L ^a   Lozano, Richard D ^a   Patt, Yehuda Z ^a   Fornage, Bruno D ^a   Vauthey, Jean Nicolas ^a   Woodall, Misty L ^a   Gonzalez, Karen B ^a   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Colorectal cancer; Hepatic artery infusion; Hepatic metastases; Radiofrequency ablation

Indexed keywords

FLOXURIDINE; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; COLORECTAL CANCER; DUODENITIS; FEASIBILITY STUDY; FEMALE; FLU LIKE SYNDROME; GASTRITIS; HAND FOOT SYNDROME; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUCOSA INFLAMMATION; PAIN; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; RADIOFREQUENCY ABLATION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; CATHETER ABLATION; COLORECTAL TUMOR; INTRAARTERIAL DRUG ADMINISTRATION; LIVER TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0041660588     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.08.019     Document Type: Article

References (36)

1. Weiss L, Grundman E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986;50:195-203.
2. Wagner J, Adson M, Van Heerden J, et al. The natural history of hepatic metastases for colorectal cancer: a comparison with resective treatment. Ann Surg 1984;199:502-8.
3. Fuhrman GM, Curley SA, Hohn DC, Roh MS. Improved survival after resection of colorectal metastases. Ann Surg Oncol 1995;2:537-41.
4. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8.
5. LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Intervent Radiol 1997;14:313-24.
6. McGahan JP, Dodd GD. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001;176:3-16.
7. Curley S. Radiofrequency ablation of malignant liver tumors. Oncologist 2001;6:14-23.
8. Pearson AS, Izzo F, Fleming RYD, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592-8.
9. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593-600.
10. Bowles BJ, Machi J, Limm WM, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864-9.
11. Lencioni R, Goletti O, Armillotta N, et al. Radio-frequency thermal ablation of liver metastases with cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998;8:1205-11.
12. De Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000;175:1619-25.
13. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of liver metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-66.
14. Ridge JA, Bading JR, Gelbard AS, et al. Perfusion of colorectal hepatic metastases: relative distribution of flow from the hepatic artery and portal vein. Cancer 1987;59:1547-53.
15. Alexander HR, Bartlett DL, Raker DL, Libutti SK. Regional treatment strategies for unresectable primary or metastatic cancer confined to the liver. In: DeVita VT, Hellman S, Rosenberg SA, eds. PPO Updates. Principles and Practice of Oncology, vol 10. Philadelphia: Lippincott-Raven, 1996:19.
16. Ellis LM, Chase J, Patt Y, Curley SA. Hepatic artery infusion chemotherapy for colorectal cancer metastasis to the liver. In: Pollock RE, Curley SA, eds. Liver Cancer. M.D. Anderson Solid Tumor Series. New York: Springer-Verlag, 1998:150-72.
17. Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: is there a survival difference? Meta-analysis of the published literature. Cancer 1996;78:1639-45.
18. Kemeny N, Huang Y, Cohen A, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-48.
19. Jenkins LT, Millikan KW, Bines SD, et al. Hepatic resection of metastatic colorectal cancer. Am Surg 1997;63:605-10.
20. Hananel N, Garzon J, Gordon PH. Hepatic resection for colorectal liver metastases. Am Surg 1995;61:444-7.
21. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
22. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced colorectal cancer meta-analysis project. J Clin Oncol 1993;10: 896-903.
23. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced colorectal cancer meta-analysis project. J Clin Oncol 1994;12:960-9.
24. Jamison RL, Donohue JH, Nagorney DM, et al. Hepatic resection for metastatic colorectal cancer results in cure of some patients. Arch Surg 1997;132:505-11.
25. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000;343:905-14.
26. Kemeny NE, Ron IG. Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol 1999;26:524-35.
27. Kemeny N, Gonen M, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001;19:2687-95.
28. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg 1999;230:309-18.
29. Kemeny MM, Adak S, Gray B, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol 2002;20:1499-505.
30. Lorenz M, Muller H, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 1998;228:756-62.
31. Ambiru S, Miyazaki HI, Nakagawa K, et al. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases. Br J Surg 1999;86:1025-31.
32. Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin North Am 2003;12:243-55.
33. Tsao J, Loftus J, Magorney D, et al. Trends in morbidity and mortality of hepatic resection for malignancy. Ann Surg 1994;220:199-205.
34. Furhman G, Curley S, Hohn D, et al. Improved survival after resection of colorectal liver metastases. Ann Surg 1995;2:537-41.
35. Fong Y, Cohen A, Fortner J, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
36. Stagg RJ, Vennok AP, Chase JL, et al. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 1991;83:423-8.